← Leaderboards
Gary S Nabors
Emergent Biosolutions
$3,770,842
Attributed
$3,770,842
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.1M · FY2005–06$2.5M$1.9M$1.3M$625K$0
'05
'06
Funding mix
By agency
NIH$3,770,842 · 2
By mechanism
U01$3,770,842 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseImmunologic Assay /TestT LymphocyteClinical Trial Phase IInfection Related Neoplasm /CancerFlow CytometryGastric MucosaGastrointestinal InfectionGenetically Modified AnimalsHelicobacterHuman SubjectImmunomodulatorsLyophilizationPatient Oriented ResearchPeptic UlcerPharmacokineticsStomach NeoplasmsVaccine DevelopmentAdult Human (21+)Vaccine EvaluationBacterial VaccinesCancer PreventionCooperative StudyDosage
Grant awards (4)
Anthrax Immune Globulin to Prevent & Treat Anthrax: Advanced Product Development$1,998,521
U01 · FY2006 · AI · contact PI
Developing an inactivated whole cell H. pylori vaccine$105,502
U01 · FY2006 · AI · contact PI
Developing an inactivated whole cell H. pylori vaccine$1,259,746
U01 · FY2005 · AI
Developing an inactivated whole cell H. pylori vaccine$407,073
U01 · FY2004 · AI